HIV protease inhibitors and atherosclerosis
J. Clin. Invest. David Y. Hui, et al. 111:317 doi:10.1172/JCI17746 [Go to this article.]

Figure 1
Schematic diagram depicting mechanisms by which HIV protease inhibitors may promote atherosclerosis through increased accumulation of SREBP. pSREBP, precursor form of SREBP; mSREBP, mature form of SREBP.